Experienced in Anemia

Dr. Kristin Anderson

Hematology
Marin Cancer Care Inc.
1350 S Eliseo Dr Ste 200, 
Greenbrae, CA 
Clinical Trials:Currently Recruiting for 1 Trial
17 Years of Experience
Experienced in Anemia
Marin Cancer Care Inc.
1350 S Eliseo Dr Ste 200, 
Greenbrae, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kristin Anderson is a Hematologist in Greenbrae, California. Dr. Anderson has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Anemia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Polycythemia Vera, and Chronic Lymphocytic Leukemia (CLL).

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Hematology
Hospital Affiliations
Marinhealth Medical Center
Novato Community Hospital
Sonoma Valley Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 10 Less Insurance Carriers -

Locations

Marin Cancer Care Inc.
1350 S Eliseo Dr Ste 200, Greenbrae, CA 94904
Other Locations
Jennifer Moreno Department of Veterans Affairs Medical Center
3350 La Jolla Village Dr, San Diego, CA 92161

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
Enrollment Status: Recruiting
Publish Date: March 01, 2024
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Phase II, Multicenter, Randomized, Open-label Study to Evaluate the Safety and Efficacy of 400 mg of Ribociclib in Combination With Non-steroidal Aromatase Inhibitors for the Treatment of Pre- and Postmenopausal Women With Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
A Phase II, Multicenter, Randomized, Open-label Study to Evaluate the Safety and Efficacy of 400 mg of Ribociclib in Combination With Non-steroidal Aromatase Inhibitors for the Treatment of Pre- and Postmenopausal Women With Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole or Anastrozole, Goserelin
Study Phase: Phase 2
Randomized Crossover Ph3 to Evaluate Efficacy/Safety of Enobosarm Monotherapy vs Active Control for Treatment of AR+/ER+/HER2- MBC With AR Staining Previously Treated w/Nonsteroidal Aromatase Inhibitor, SERD & CDK 4/6 Inhibitor
Randomized Crossover Ph3 to Evaluate Efficacy/Safety of Enobosarm Monotherapy vs Active Control for Treatment of AR+/ER+/HER2- MBC With AR Staining Previously Treated w/Nonsteroidal Aromatase Inhibitor, SERD & CDK 4/6 Inhibitor
Enrollment Status: Terminated
Publish Date: January 26, 2024
Intervention Type: Drug
Study Drugs: Enobosarm, Exemestane
Study Phase: Phase 3
View 3 Less Clinical Trials

2 Total Publications

Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Journal: Blood cells, molecules & diseases
Published: August 18, 2015
Similar Doctors
Elite in Anemia
Dr. Elliott Vichinsky
Hematology | Oncology
Elite in Anemia
Dr. Elliott Vichinsky
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (16.5 miles away)
510-428-3372
Languages Spoken:
English
See accepted insurances

Elliott Vichinsky is a Hematologist and an Oncologist in Oakland, California. Dr. Vichinsky is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Elite in Anemia
Dr. Mark Walters
Hematology | Oncology
Elite in Anemia
Dr. Mark Walters
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (16.5 miles away)
510-428-3374
Languages Spoken:
English
See accepted insurances

Mark Walters is a Hematologist and an Oncologist in Oakland, California. Dr. Walters is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Hemoglobinopathy, Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Elite in Anemia
Dr. Ashutosh Lal
Hematology | Oncology
Elite in Anemia
Dr. Ashutosh Lal
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (16.5 miles away)
510-428-3374
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Lal is a Hematologist and an Oncologist in Oakland, California. Dr. Lal is rated as an Elite provider by MediFind in the treatment of Anemia. His top areas of expertise are Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anderson's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 73 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile